SCHEMBL5809144

SCHEMBL5809144

Cc1cc(CC(=O)NS(=O)(=O)c2ccc(Cc3ccc(F)cc3)s2)n(-c2ccccc2)n1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.46
EGFR P00533 3/20 0.41
ERBB2 P04626 3/20 0.41
ALDH1A1 P00352 7/20 0.40
HTT P42858 3/20 0.40
KDM4E B2RXH2 1/20 0.40
P2RY1 P47900 1/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TP53 P04637 1/20 0.36
NTRK1 P04629 1/20 0.35
P2RX7 Q99572 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CACNA1G O43497 1/20 0.35
CACNA1H O95180 1/20 0.35
KCNH2 Q12809 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5805117 0.85 ALDH1A1 (0.41) MAPTALDH1A1HTTLMNASMN1; SMN2
SCHEMBL5820740 0.83 ALDH1A1 (0.43) MAPTEGFRERBB2ALDH1A1HTT
SCHEMBL5807701 0.81 MEN1 (0.41) MAPTALDH1A1HTTLMNASMN1; SMN2
SCHEMBL5809123 0.78 NTRK1 (0.38) ALDH1A1HTTLMNASMN1; SMN2NTRK1
SCHEMBL5815233 0.78 PTGES (0.35) EGFRERBB2
SCHEMBL5806376 0.78 NTRK1 (0.37) ALDH1A1HTTLMNASMN1; SMN2NTRK1
SCHEMBL5804900 0.77 MAPK13 (0.47) MAPTEGFRERBB2ALDH1A1LMNA
SCHEMBL5806852 0.77 ALDH1A1 (0.50) EGFRERBB2ALDH1A1HTTNTRK1
SCHEMBL8262196 0.77 GUSB (0.44) ALDH1A1HTTLMNASMN1; SMN2TP53
SCHEMBL5804793 0.76 AKR1C3 (0.40) EGFRERBB2ALDH1A1HTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006075955-A1 PYRAZOLYL ACYLSULFONAMIDE DERIVATIVES AS ENDOTHELIN CONVERTING ENZYME INHIBITORS AND USEFUL IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASTRAZENECA AB (SE) 2006-07-20 WO disclosed